Sp1 binding plays a critical role in Erb-B2- and v-ras-mediated downregulation of α2-integrin expression in human mammary epithelial cells

Molecular and Cellular Biology

Volumn 16, Issue 11, 1996, Pages 6178-6189

  Ye, Jianping ^a   Xu, Ruo Hui ^a   Taylor Papadimitriou, Joyce ^b   Pitha, Paula M ^a,c  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

^c JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTEGRIN;

ARTICLE; BREAST CARCINOGENESIS; BREAST CARCINOMA; BREAST EPITHELIUM; DOWN REGULATION; GENE DELETION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSCRIPTION REGULATION;

EID: 10244252704     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/mcb.16.11.6178     Document Type: Article

References (59)

1. Alford, D., and J. Taylor-Papadimitriou. 1996. Cell adhesion molecules in the normal and cancerous mammary gland. J. Mammary Gland Biol. Neoplasia 1:207-218.
2. Bacus, S. S., A. V. Gudkov, C. R. Zelnick, D. Chin, R. Stern, I. Stancovski, E. Peles, N. Ben-Baruch, H. Farbstein, R. Lupu, D. Wen, M. Sela, and Y. Yarden. 1993. Neu differentiation factor (Heregulin) induces expression of intercellular adhesion molecule 1: implications for mammary tumors. Cancer Res. 53:5251-5261.
3. Bartek, J., J. Bartkova, N. Kyprianou, E.-N. Lalani, Z. Staskova, M. Shearer, S. Chang, and J. Taylor-Papadimitriou. 1991. Efficient immortalization of luminal epithelial cells from human mammary gland by introduction of simian virus 40 large tumor antigen with a recombinant retrovirus. Proc. Natl. Acad. Sci. USA 88:3520-3524.
4. Beerli, R. R., D. Graus-Porta, K. Woods-Cook, X. Chen, Y. Yarden, and N. E. Hynes. 1995. Neu differentiation factor activation of ErbB-3 and ErbB-4 is cell specific and displays a differential requirement for ErbB-2. Mol. Cell. Biol. 15:6496-6506.
5. Behrens, J., O. Lowrick, L. Klein-Hitpass, and W. Birchmeier. 1991. The E-cadherin promoter: functional analysis of a G·C-rich region and an epithelial cell-specific palindromic regulatory element. Proc. Natl. Acad. Sci. USA 88:11495-11499.
6. Ben-Levy, R., H. F. Paterson, C. J. Marshall, and Y. Yarden. 1994. A single autophosphorylation site confers oncogenicity to the Neu/ErbB-2 receptor and enables coupling to the MAP kinase pathway. EMBO J. 13:3302-3311.
7. Benoist, C., and P. Chambon. 1981. In vivo sequence requirements of the SV40 early promoter region. Nature (London) 290:304-310.
8. Berdichevsky, F., D. Alford, B. D'Souza, and J. Taylor-Papadimitriou. 1994. Branching morphogenesis of human mammary epithelial cells in collagen gels. J. Cell Sci. 107:3557-3568.
9. Berdickevsky, F., R. Wetzels, M. Shearer, S. Martignone, F. C. S. Raemakers, and J. Taylor-Papadimitriou. 1994. Integrin expression in relation to cell phenotype and malignant change in the human breast. Mol. Cell Differ. 2:255-274.
10. Bosher, J. M., T. Williams, and J. C. Hurst. 1995. The developmentally regulated transcription factor AP-2 is involved in c-erbB-2 overexpression in human mammary carcinoma. Proc. Natl. Acad. Sci. USA 92:744-747.
11. Carson, E. B., M. McMahon, S. B. Baylin, and B. D. Nelkin. 1995. Ret gene silencing is associated with Raf-1-induced medullary thyroid carcinoma cell differentiation. Cancer Res. 55:2048-2052.
12. Chen, L. I., T. Nishinaka, K. Kwan, I. Kitabayashi, K. Yokoyama, Y.-S. F. Fu, S. Grunwald, and R. Chiu. 1994. The retinoblastoma gene product RB stimulates Sp1-mediated transcription by liberating Sp1 from a negative regulator. Mol. Cell. Biol. 14:4380-4389.
13. Cippitelli, M., A. Sica, V. Viggiano, J. Ye, P. Ghosh, M. J. Birrer, and H. A. Young. 1995. Negative transcriptional regulation of the interferon-γ promoter by blucocorticoids and dominant negative mutants of c-Jun. J. Biol. Chem. 270:12548-12556.
14. Clark, E. A., and J. S. Brugge. 1995. Integrins and signal transduction pathways: the road taken. Science 268:233-239.
15. Courey, A. J., and R. Tjian. 1988. Analysis of Sp1 in vivo reveals multiple transcriptional domains, including a novel glutamine-rich activation motif. Cell 55:887-898.
16. 2-integrin subunit is inhibited in c-erbB2-transfected human mammary epithelial cells. Oncogene 8:1797-1806.
17. D'Souza, B., and J. Taylor-Papadimitriou. 1994. Overexpression of ERBB2 in human mammary epithelial cells signals inhibition of transcription of the E-cadherin gene. Proc. Natl. Acad. Sci. USA 91:7202-7206.
18. Egan, S. E., B. W. Giddings, M. W. Brooks, L. Buday, A. M. Sizeland, and R. A. Weinberg. 1993. Association of Sos Ras exchange protein with Grb2 is implicated in tyrosine kinase signal transduction and transformation. Nature (London) 363:45-51.
19. II110 component of the Drosophila TFIID complex and mediates transcriptional activation. Proc. Natl. Acad. Sci. USA 91:192-196.
20. Graff, J. R., J. G. Herman, R. G. Lapidus, H. Chopra, R. Xu, D. F. Jarrard, W. B. Isaacs, P. M. Pitha, N. E. Davidson, and S. B. Baylin. 1995. E-cadherin expression is silenced by DNA hypermethylation in human breast and prostate carcinomas. Cancer Res. 55:5195-5199.
21. Graus-Porta, D., R. R. Beerli, and N. E. Hynes. 1995. Single-chain antibody-mediated intracellular retention of ErbB-2 impairs Neu differentiation factor and epidermal growth factor signaling. Mol. Cell. Biol. 15:1182-1191.
22. Gum, R., S. W. Wang, E. Lengyel, D. Yu, M. C. Hung, J. Juarez, and D. Boyd. 1995. Upregulation of urokinase-type plasminogen activator expression by the HER2/neu proto-oncogene. Anticancer Res. 15:1167-1172.
23. Hagen, G., S. Muller, M. Beato, and G. Suske. 1994. Sp1-mediated transcriptional activation is repressed by Sp3. EMBO J. 13:3843-3851.
24. Hennig, G., J. Behrens, M. Truss, S. Frisch, E. Reichmann, and W. Birchmeir. 1995. Progression of carcinoma cells is associated with alterations in chromatin structure and factor binding of the E-cadherin promoter in vitro. Oncogene 11:475-484.
25. Imagawa, M., R. Chiu, and M. Karin. 1987. Transcription factor AP-2 mediates induction by two different signal-transduction pathways: protein kinase C and cAMP. Cell 51:251-260.
26. Jackson, S. P., J. J. MacDonald, S. Lees-Miller, and R. Tjian. 1990. GC box binding induces phosphorylalion of Sp1 by a DNA-dependent protein kinase. Cell 63:155-165.
27. Kadonaga, J. T., K. R. Carner, F. R. Masiarz, and R. Tjian. 1987. Isolation of cDNA encoding transcription factor Sp1 and functional analysis of the DNA binding domain. Cell 51:1079-1090.
28. Karunagaran, D., E. Tzahar, R. R. Beerli, X. Chen, D. Graus-Porta, B. J. Ratzkin, R. Seger, N. E. Hynes, and Y. Yarden. 1996. ErbB-2 is a common auxiliary subunit of NDF and EGF receptors: implications for breast cancer. EMBO J. 15:254-264.
29. King, C. R., M. H. Kraus, and S. A. Aaronson. 1985. Amplification of a novel v-erbB-related gene in a human mammary carcinoma. Science 229:974-978.
30. Kingsley, C., and A. Winto. 1992. Cloning of GT box-binding proteins: a novel Sp1 multigene family regulating T-cell receptor gene expression. Mol. Cell. Biol. 12:4251-4261.
31. Kovarik, A., P. J. Lu, N. Peat, J. Morris, and J. Taylor-Papadimitriou. Two GC boxes (Sp1 sites) are involved in regulation of the activity of the epithelial specific MUC-1 promoter. J. Biol. Chem., in press.
32. Kraus, M. H., W. Issing, T. Miki, N. C. Popescu, and S. A. Aaronson. 1989. Isolation and characterization of ERBB3, a third member of the ERBB/epidermal growth factor receptor family: evidence for overexpression in a subset of human mammary tumors. Proc. Natl. Acad. Sci. USA 86:9193-9197.
33. Kumar, C. C., P. Bushel, S. Mohan-Peterson, and F. Ramirez. 1992. Regulation of smooth muscle α-actin promoter in ras-transformed cells: usefulness for setting up reporter gene-based assay system for drug screening. Cancer Res. 52:6877-6884.
34. Lu, P. J., Q. L. Lu, A. Rughetti, and J. Taylor-Papadimitriou. 1995. bcl-2 overexpression inhibits cell death and promotes the morphogenesis, but not tumorigenesis of human mammary epithelial cells. J. Cell Biol. 129:1363-1378.
35. Majello, B., P. De Luca, G. Hagen, G. Suske, and L. Lania. 1994. Different members of the Sp1 multigene family exert opposite transcriptional regulation of the long terminal repeat of HIV-1. Nucleic Acids Res. 22:4914-4921.
36. Mitchell, P. J., and R. Tjian. 1989. Transcriptional regulation in mammalian cells by sequence-specific DNA binding proteins. Science 245:371-378.
37. Mosca, J. D., D. P. Bednarik, N. B. K. Raj, C. A. Rosen, J. G. Sodroski, W. A. Haseltine, G. S. Hayward, and P. M. Pitha. 1987. Activation of human immunodeficiency virus by herpesvirus infection: identification of a region within the long terminal repeat that responds to a trans-acting factor encoded by herpes simplex virus 1. Proc. Natl. Acad. Sci. USA 84:7408-7412.
38. Muthuswamy, S. K., P. M. Siegel, D. L. Dankort, M. A. Webster, and W. J. Muller. 1994. Mammary tumors expressing the neu proto-oncogene possess elevated c-Src tyrosine kinase activity. Mol. Cell. Biol. 14:735-743.
39. Neish, A. S., M. A. Read, D. Thanos, R. Pine, T. Maniatis, and T. Collins. 1995. Endothelial interferon regulatory factor 1 cooperates with NF-κB as a transeriptional activator of vascular cell adhesion molecule 1. Mol. Cell. Biol. 15:2558-2559.
40. Noti, J. D., R. C. Reinemann, and M. N. Petrus. 1996. Sp1 binds two sites in the CD11c promoter in vivo specifically in myeloid cells and cooperates with Ap1 to activate transcription. Mol. Cell. Biol. 16:2940-2950.
41. Oda, T., Y. Kanai, T. Oyama, K. Yoshiura, Y. Shimoyama, W. Birchmeier, T. Sugimura, and S. Hirohashi. 1994. E-cadherin gene mutations in human gastric carcinoma cell lines. Proc. Natl. Acad. Sci. USA 91:1858-1862.
42. Oka, H., H. Shiozaki, K. Kobayashi, M. Inoue, H. Tahara, T. Kobayashi, Y. Takalskua, N. Matsuyoshi, S. Hirono, M. Takeichi, and T. Mori. 1993. Expression of E-cadherin cell adhesion molecules in human breast cancer tissues and its relationship to metastasis. Cancer Res. 53:5104-5109.
43. Pugh, B. F., and R. Tjian. 1991. Transcription from a TATA-less promoter requires a multisubunit TFIID complex. Genes Dev. 5:1935-1945.
44. Qian, X., W. C. Dougall, Z. Fei, and M. I. Greene. 1995. Intermolecular association and trans-phosphorylation of different neu-kinase forms permit SH2-depcndent signaling and oncogenic transformation. Oncogene 10:211-219.
45. Reichmann, E., H. Schwarz, E. M. Deiner, I. Leitner, M. Eilers, J. Berger, M. Busslinger, and H. Beug. 1992. Activation of an inducible c-FosER fusion protein causes loss of epithelial polarity and triggers epithelial-fibroblastoid cell conversion. Cell 71:1103-1116.
46. Slamon, D. J., C. M. Clark, S. G. Wong, W. J. Levin, A. Ullrich, and W. L. McGuire. 1987. Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Nature (London) 366:177-182.
47. Tan, T.-H., C. P. Huang, A. Sica, P. Ghosh, H. A. Young, D. L. Longo, and N. R. Rice. 1992. KB site-dependent activation of the interleukin-2 receptor α-chain gene promoter by human C-Rel. Mol. Cell. Biol. 12:4067-4075.
48. Udvadia, A. J., D. J. Templeton, and J. M. Horowitz. 1995. Functional interactions between the retinoblastoma (Rb) protein and Sp-family members: superactivation by Rb requires amino acids necessary for growth suppression. Proc. Natl. Acad. Sci. USA 92:3953-3957.
49. Ullrich, A., and J. Schlessinger. 1990. Signal transduction by receptors with tyrosine kinase activity. Cell 61:203-212.
50. Umbas, R., J. A. Schalken, T. W. Aalders, B. S. Carter, H. F. M. Karthasu, H. E. Schaafsma, F. M. J. Debruyne, and W. B. Isaacs. 1992. Expression of the cellular adhesion molecule E-cadherin is reduced or absent in high-grade prostate cancer. Cancer Res. 52:5104-5109.
51. Vlach, J., and P. M. Pitha. 1992. Activation of human immunodeficiency virus type 1 provirus in T-cells and macrophages is associated with induction of inducer-specifie NF-κB binding proteins. Virology 187:63-72.
52. Williams, T., A. Admon, B. Luscher, and R. Tjian. 1988. Cloning and expression of AP-2, a cell-type-spccific transcription factor that activates inducible enhancer elements. Genes Dev. 2:1557-1569.
53. Yarden, Y., and A. Ullrich. 1988. Growth factor receptor tyrosine kinases. Annu. Rev. Biochem. 57:443-478.
54. Ye, J., P. Ghosh, M. Cippitelli, J. Subleski, K. J. Hardy, J. R. Ortaldo, and H. A. Young. 1994. Characterization of a silencer regulatory clement in the human interferon-γ promoter. J. Biol. Chem. 269:25728-25734.
55. Ye, J., X. Zhang, and Z. Dong. 1996. Characterization of the human granulocyte-macrophage colony-stimulation factor gene promoter: an AP1 complex and an Sp1-related complex transactivate the promoter activity that is suppressed by a YY1 complex. Mol. Cell. Biol. 16:157-167.
56. Yoshiura, K., Y. Kanai, A. Ochiai, Y. Shimoyama, T. Sugimura, and S. Hirohashi. 1995. Silencing of the E-cadherin invasion-suppressor gene by CpG methylation in human carcinomas. Proc. Natl. Acad. Sci. USA 92:7416-7419.
57. Zutter, M. M., H. R. Krigman, and S. A. Santoro. 1993. Altered integrin expression in adenocarcinoma of the breast. Analysis by in situ hybridization. Am. J. Pathol. 142:1439-1448.
58. Zutter, M. M., G. Mazoujian, and S. A. Santoro. 1990. Decreased expression of integrin adhesive protein receptors in adenocarcinoma of the breast. Am. J. Pathol. 137:863-870.
59. Zutter, M. M., S. A. Santoro, A. S. Painter, Y. L. Tsung, and Z. Gafford. 1994. The human α2 integrin gene promoter. J. Biol. Chem. 269:463-469.